Erika A. Currier

1.0k total citations
26 papers, 851 citations indexed

About

Erika A. Currier is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Erika A. Currier has authored 26 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Surgery. Recurrent topics in Erika A. Currier's work include Receptor Mechanisms and Signaling (7 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (6 papers) and Apelin-related biomedical research (5 papers). Erika A. Currier is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (6 papers) and Apelin-related biomedical research (5 papers). Erika A. Currier collaborates with scholars based in United States, Sweden and Ireland. Erika A. Currier's co-authors include Uli Hacksell, Ethan S. Burstein, Mark R. Brann, Roger Olsson, Tracy A. Spalding, Terri Messier, Fabrice Piu, Niels Skjærbæk, Donghui Li and Carol Trotter and has published in prestigious journals such as Oncogene, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Erika A. Currier

26 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erika A. Currier United States 17 469 335 127 98 80 26 851
Elizabeth Webb United States 13 245 0.5× 155 0.5× 96 0.8× 145 1.5× 53 0.7× 19 746
Mei-Ping Kung United States 17 288 0.6× 316 0.9× 64 0.5× 89 0.9× 74 0.9× 19 990
Thomas J. Mangano United States 18 879 1.9× 510 1.5× 68 0.5× 45 0.5× 115 1.4× 27 1.2k
Tjeerd Barf Netherlands 19 724 1.5× 267 0.8× 360 2.8× 161 1.6× 36 0.5× 33 1.7k
David G. Witte United States 23 829 1.8× 328 1.0× 133 1.0× 55 0.6× 26 0.3× 56 1.4k
Margot W. Beukers Netherlands 27 1.0k 2.2× 418 1.2× 410 3.2× 74 0.8× 68 0.8× 42 1.9k
John N.D. Wurpel United States 19 491 1.0× 364 1.1× 87 0.7× 29 0.3× 41 0.5× 51 1.2k
Jean Zhang United States 15 423 0.9× 170 0.5× 65 0.5× 57 0.6× 95 1.2× 31 846
Satyawan Jadhav United States 20 1.1k 2.3× 876 2.6× 120 0.9× 148 1.5× 38 0.5× 41 1.6k
Bianca Plouffe Canada 19 1.1k 2.4× 587 1.8× 87 0.7× 61 0.6× 61 0.8× 34 1.5k

Countries citing papers authored by Erika A. Currier

Since Specialization
Citations

This map shows the geographic impact of Erika A. Currier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika A. Currier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika A. Currier more than expected).

Fields of papers citing papers by Erika A. Currier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika A. Currier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika A. Currier. The network helps show where Erika A. Currier may publish in the future.

Co-authorship network of co-authors of Erika A. Currier

This figure shows the co-authorship network connecting the top 25 collaborators of Erika A. Currier. A scholar is included among the top collaborators of Erika A. Currier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika A. Currier. Erika A. Currier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sholler, Giselle L. Saulnier, Erika A. Currier, Sharon Illenye, et al.. (2013). PCI-24781 (abexinostat), a novel histone deacetylase inhibitor, induces reactive oxygen species-dependent apoptosis and is synergistic with bortezomib in neuroblastoma. PubMed. 2(1). 21–21. 21 indexed citations
2.
Sun, Yujing, Girja S. Shukla, Stephanie C. Pero, et al.. (2012). Single Tumor Imaging with Multiple Antibodies Targeting Different Antigens. BioTechniques. 52(4). 216–216. 2 indexed citations
3.
Sholler, Giselle L. Saulnier, William S. Ferguson, Genevieve Bergendahl, et al.. (2012). A Pilot Trial Testing the Feasibility of Using Molecular-Guided Therapy in Patients with Recurrent Neuroblastoma. Journal of Cancer Therapy. 3(5). 602–612. 12 indexed citations
4.
Eslin, Don, Umesh T. Sankpal, Chris Lee, et al.. (2011). Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: A novel therapeutic agent for neuroblastoma. Molecular Carcinogenesis. 52(5). 377–386. 27 indexed citations
5.
Singh, Ajay, Angelica M. DeMartino, Sharon Illenye, et al.. (2011). Oral RKS262 reduces tumor burden in a neuroblastoma xenograft animal model and mediates cytotoxicity through SAPK/JNK and ROS activation in vitro. Cancer Biology & Therapy. 11(12). 1036–1045. 8 indexed citations
6.
Gustafsson, Magnus, Jacob Jensen, Sine Mandrup Bertozzi, et al.. (2010). Discovery of a class of calcium sensing receptor positive allosteric modulators; 1-(benzothiazol-2-yl)-1-phenylethanols. Bioorganic & Medicinal Chemistry Letters. 20(19). 5918–5921. 8 indexed citations
7.
Lehmann, Fredrik, Erika A. Currier, Roger Olsson, et al.. (2010). Optimization of isochromanone based urotensin II receptor agonists. Bioorganic & Medicinal Chemistry. 18(13). 4844–4854. 11 indexed citations
8.
Lehmann, Fredrik, Erika A. Currier, Bryan Clemons, et al.. (2009). Novel and potent small-molecule urotensin II receptor agonists. Bioorganic & Medicinal Chemistry. 17(13). 4657–4665. 6 indexed citations
9.
Malik, Leila, et al.. (2009). Discovery of non-peptidergic MrgX1 and MrgX2 receptor agonists and exploration of an initial SAR using solid-phase synthesis. Bioorganic & Medicinal Chemistry Letters. 19(6). 1729–1732. 17 indexed citations
10.
Pettersson, Hanna, Fredrik Ek, Jacob Jensen, et al.. (2009). Synthesis and Evaluation of Dibenzothiazepines: A Novel Class of Selective Cannabinoid-1 Receptor Inverse Agonists. Journal of Medicinal Chemistry. 52(7). 1975–1982. 31 indexed citations
11.
Tredici, Andria L. Del, K.E. Vanover, Sine Mandrup Bertozzi, et al.. (2008). Identification of novel selective V2 receptor non-peptide agonists. Biochemical Pharmacology. 76(9). 1134–1141. 5 indexed citations
12.
Schiffer, Hans H., Jean Wang, Kenneth K. Wong, et al.. (2007). Identification of the Atypical L-Type Ca2+ Channel Blocker Diltiazem and Its Metabolites As Ghrelin Receptor Agonists. Molecular Pharmacology. 72(2). 380–386. 7 indexed citations
13.
Tredici, Andria L. Del, Carsten Andersen, Erika A. Currier, et al.. (2007). Identification of the First Synthetic Steroidogenic Factor 1 Inverse Agonists: Pharmacological Modulation of Steroidogenic Enzymes. Molecular Pharmacology. 73(3). 900–908. 35 indexed citations
14.
Lehmann, Fredrik, et al.. (2006). Design, parallel synthesis and SAR of novel urotensin II receptor agonists. European Journal of Medicinal Chemistry. 42(2). 276–285. 33 indexed citations
15.
Burstein, Ethan S., Fabrice Piu, Jian‐Nong Ma, et al.. (2006). Integrative Functional Assays, Chemical Genomics and High Throughput Screening: Harnessing Signal Transduction Pathways to a Common HTS Readout. Current Pharmaceutical Design. 12(14). 1717–1729. 28 indexed citations
16.
Lehmann, Fredrik, Erika A. Currier, Roger Olsson, Uli Hacksell, & Kristina Luthman. (2005). Isochromanone-based urotensin-II receptor agonists. Bioorganic & Medicinal Chemistry. 13(8). 3057–3068. 26 indexed citations
17.
Piu, Fabrice, Roger Olsson, Erika A. Currier, et al.. (2005). Identification of novel subtype selective RAR agonists. Biochemical Pharmacology. 71(1-2). 156–162. 30 indexed citations
18.
Ma, Jian‐Nong, Erika A. Currier, Anthony Essex, et al.. (2004). Discovery of novel peptide/receptor interactions: identification of PHM-27 as a potent agonist of the human calcitonin receptor. Biochemical Pharmacology. 67(7). 1279–1284. 8 indexed citations
19.
Spalding, Tracy A., Carol Trotter, Niels Skjærbæk, et al.. (2002). Discovery of an Ectopic Activation Site on the M1Muscarinic Receptor. Molecular Pharmacology. 61(6). 1297–1302. 156 indexed citations
20.
Burstein, Ethan S., et al.. (1998). The ras-related GTPase rac1 regulates a proliferative pathway selectively utilized by G-protein coupled receptors. Oncogene. 17(12). 1617–1623. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Webb Breakdown of academic impact, for papers by Mei-Ping Kung Breakdown of academic impact, for papers by Thomas J. Mangano Breakdown of academic impact, for papers by Tjeerd Barf Breakdown of academic impact, for papers by David G. Witte Breakdown of academic impact, for papers by Margot W. Beukers Breakdown of academic impact, for papers by John N.D. Wurpel Breakdown of academic impact, for papers by Jean Zhang Breakdown of academic impact, for papers by Satyawan Jadhav Breakdown of academic impact, for papers by Bianca Plouffe
Rankless by CCL
2026